Early Integrated Palliative Care Bundle Impacts Location of Death in Interstitial Lung Disease: A Pilot Retrospective Study

Abstract

Background:

Interstitial lung diseases (ILDs) comprise a heterogeneous group of fibrotic, progressive pulmonary diseases characterized by poor end-of-life care and hospital deaths. In 2012, we launched our Multidisciplinary Collaborative (MDC) ILD clinic to deliver integrated palliative approach throughout disease trajectory to improve care. We sought to explore the effects of palliative care and other factors on location of death (LOD) of patients with ILD.

Methods:

The MDC-ILD clinic implemented a palliative care bundle including advance care planning (ACP), opiates use, allied health home care engagement, and use of supplemental oxygen and early caregiver engagement in care. Data from patients with ILD who attended the clinic and died between 2012 and 2019 were used to generate scores representing the components and duration of palliative care (palliative care bundle score) and caregiver involvement (caregiver engagement score). We examined the impact of these scores on patients’ LOD.

Results:

A total of 92 MDC-ILD clinic patients were included, 57 (62%) had home or hospice deaths. Patients who died at home or hospice had higher palliative care bundle scores (10.0 ± 4.0 vs 7.8 ± 3.9, P = .01) and caregiver engagement scores (1.7 ± 0.6 vs 1.3 ± 0.7, P = .01) compared to those who died in hospital. Patients were 1.13 times more likely to die at home or hospice following a 1-point increase in palliative care bundle score (95% CI: 1.01-1.29, P = .04) and 2.38 times more likely following a 1-point increase in caregiver engagement score (95% CI: 1.17-5.15, P = .02).

Conclusions:

Home and hospice deaths are feasible in ILD. Early initiation of palliative care bundle components such as ACP discussions, symptom self-management, caregiver engagement, and close collaboration with allied health home care supports can promote adherence to patient preference for home or hospice deaths.

Keywords

interstitial lung diseases early integrated palliative care location of death home death end of life pulmonary fibrosis multidisciplinary advance care planning

Get full access to this article

View all access options for this article.

References

Rajala

Lehto

Sutinen

Kautiainen

Myllärniemi

Saarto

. Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life. BMC Pulm Med. 2018;18(1):172.

Pittrow

Klotsche

Kreuter

, et al. Symptom burden and health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-Ipf registry. Value Health. 2014;17(7):A600.

Bajwah

Higginson

Ross

, et al. Specialist palliative care is more than drugs: a retrospective study of ILD patients. Lung. 2012;190(2):215–220.

Lindell

Liang

Hoffman

, et al. Palliative care and location of death in decedents with idiopathic pulmonary fibrosis. Chest. 2015;147(2):423–429.

Liang

Hoffman

Nouraie

, et al. Referral to palliative care infrequent in patients with idiopathic pulmonary fibrosis admitted to an intensive care unit. J Palliat Med. 2017;20(2):134–140.

Rajala

Lehto

Saarinen

Sutinen

Saarto

Myllärniemi

. End-of-life care of patients with idiopathic pulmonary fibrosis. BMC Palliat Care. 2016;15(1):85.

Ahmadi

Wysham

Lundström

Janson

Currow

Ekström

. End-of-life care in oxygen-dependent ILD compared with lung cancer: a national population-based study. Thorax. 2016;71(6):510–516.

Burge

Lawson

Johnston

Asada

McIntyre

Flowerdew

. Preferred and actual location of death: what factors enable a preferred home death? J Palliat Med. 2015;18(12):1054–1059.

Higginson

Reilly

Bajwah

Maddocks

Costantini

Gao

. Which patients with advanced respiratory disease die in hospital? A 14-year population-based study of trends and associated factors. BMC Med. 2017;15(1):19.

10.

Curtis

Patrick

Engelberg

Norris

Asp

Byock

. A measure of the quality of dying and death: initial validation using after-death interviews with family members. J Pain Symptom Manage. 2002;24(1):17–31.

11.

Horsfall

Leonard

Rosenberg

Noonan

. Home as a place of caring and wellbeing? A qualitative study of informal carers and caring networks lived experiences of providing in-home end-of-life care. Health Place. 2017;46:58–64.

12.

Tanuseputro

Wodchis

Fowler

, et al. The health care cost of dying: a population-based retrospective cohort study of the last year of life in Ontario, Canada. PLoS One. 2015;10(3):e0121759.

13.

Vaidya

Hibbert

Kinter

Boes

. Identification of key cost generating events for idiopathic pulmonary fibrosis: A systematic review. Lung. 2017;195(1):1–8.

14.

Wright

Keating

Balboni

Matulonis

Block

Prigerson

. Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers’ mental health. J Clin Oncol. 2010;28(29):4457–4464.

15.

Abel

Pring

Rich

Malik

Verne

. The impact of advance care planning of place of death, a hospice retrospective cohort study. BMJ Support Palliat Care. 2013;3(2):168–173.

16.

Rosenberg

Bullen

Maher

. Supporting family caregivers with palliative symptom management: a qualitative analysis of the provision of an emergency medication kit in the home setting. Am J Hosp Palliat Care. 2015;32(5):484–489.

17.

Seow

Brazil

Sussman

, et al. Impact of community based, specialist palliative care teams on hospitalisations and emergency department visits late in life and hospital deaths: a pooled analysis. BMJ. 2014;348:g3496.

18.

Higginson

Bausewein

Reilly

, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med. 2014;2(12):979–987.

19.

Qureshi

Tanuseputro

Perez

Pond

Seow

. Early initiation of palliative care is associated with reduced late-life acute-hospital use: a population-based retrospective cohort study. Palliat Med. 2019;33(2):150–159.

20.

Tang

McCorkle

. Determinants of place of death for terminal cancer patients. Cancer Invest. 2001;19(2):165–180.

21.

Huang

Chen

, et al. Factors predicting a home death among home palliative care recipients. Medicine (Baltimore). 2017;96(41):e8210.

22.

Fukui

Kawagoe

. Predictors of place of death for Japanese patients with advanced-stage malignant disease in home care settings: a nationwide survey. Cancer. 2004;101(2):421–429.

23.

Kalluri

Richman-Eisenstat

. From consulting to caring: care redesign in idiopathic pulmonary fibrosis. NEJM Catalyst website. 2019. Published March 28, 2019. Accessed October 28, 2019. https://catalyst.nejm.org/idiopathic-pulmonary-fibrosis-care

24.

Higginson

Jarman

Astin

Dolan

. Do social factors affect where patients die: An analysis of 10 years of cancer deaths in England. J Public Health Med. 1999;21(1):22–28.

25.

Gomes

Higginson

. Factors influencing death at home in terminally ill patients with cancer: systematic review. BMJ. 2006;332(7540):515–521.

26.

Pampalon

Raymond

. A deprivation index for health and welfare planning in Quebec. Chronic Dis Can. 2000;21(3):104–113.

27.

Ishikawa

Fukui

Okamoto

. Advance care planning and home death in patients with advanced cancer: a structured interview analysis. Int J Palliat Nurs. 2018;24(9):418–426.

28.

Webber

Viola

Knott

Peng

Groome

. Community palliative care initiatives to reduce end-of-life hospital utilization and in-hospital deaths: a population-based observational study evaluating two home care interventions. J Pain Symptom Manage. 2019;58(2):181–189.

29.

Prioleau

Soones

Ornstein

Zhang

Smith

Wajnberg

. Predictors of place of death of individuals in a home-based primary and palliative care program. J Am Geriatr Soc. 2016;64(11):2317–2321.

30.

Health Quality Ontario. Team-based models for end-of-life care: an evidence-based analysis. Ont Health Technol Assess Ser. 2014;14(20):1–49.

31.

Kalluri

Claveria

Ainsley

Haggag

Armijo-Olivo

Richman-Eisenstat

. Beyond idiopathic pulmonary fibrosis diagnosis: multidisciplinary care with an early integrated palliative approach is associated with a decrease in acute care utilization and hospital deaths. J Pain Symptom Manage. 2018;55(2):420–426.

32.

McEwen

Asada

Burge

Lawson

. Associations between home death and the use and type of care at home. J Palliat Care. 2018;33(1):26–31.

33.

Bell

Somogyi-Zalud

Masaki

. Factors associated with congruence between preferred and actual place of death. J Pain Symptom Manage. 2010;39(3):591–604.

34.

Sampson

Gill

Harrison

Nelson

Byrne

. The care needs of patients with idiopathic pulmonary fibrosis and their carers (CaNoPy): results of a qualitative study. BMC Pulm Med. 2015;15(1):155.

35.

Dunlop

Davies

Hockley

. Preferred versus actual place of death: a hospital palliative care support team experience. Palliat Med. 1989;3(3):197–201.

36.

Kreuter

Bendstrup

Russell

, et al. Palliative care in interstitial lung disease: Living well. Lancet Respir Med. 2017;5(12):968–980.

37.

Kalluri

Lu-Song

Younus

, et al. Health care costs at end-of-life for patients with idiopathic pulmonary fibrosis: evaluation of a pilot multidisciplinary clinic. Ann Am Thorac Soc. 2020; 17(6):706–713. Forthcoming. https://doi.org/10.1513/AnnalsATS.201909-707OC

38.

Raghu

Collard

Egan

, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824.

39.

Pooler

Richman-Eisenstat

Kalluri

. Early integrated palliative approach for idiopathic pulmonary fibrosis: a narrative study of bereaved caregivers’ experiences. Palliat Med. 2018;32(9):1455–1464.

40.

Kalluri

Richman-Eisenstat

. Breathing is not an option; dyspnea is. J Palliat Care. 2014;30(3):188–191.

41.

Kalluri

Richman-Eisenstat

. Early and integrated palliative care to achieve a home death in idiopathic pulmonary fibrosis. J Pain Symptom Manage. 2017;53(6):1111–1115.

42.

Kalluri

Bakal

Ting

Younus

. Comparison of MRC breathlessness scale to a novel multidimensional dyspnea scale (MDDS) for clinical use. Am J Respir Crit Care Med. 2019;199:A3371.

43.

Guenther

Krauss

Tello

, et al. The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis. Respir Res. 2018;19(1):141.

44.

Kreuter

Swigris

Pittrow

, et al. Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry. Respir Res. 2017;18(1):139.

45.

Ryerson

Donesky

Pantilat

Collard

. Dyspnea in idiopathic pulmonary fibrosis: a systematic review. J Pain Symptom Manage. 2012;43(4):771–782.

46.

Gentzler

Derry

Ouyang

, et al. Underdetection and undertreatment of dyspnea in critically ill patients. Am J Respir Crit Care Med. 2019;199(11):1377–1384.

47.

Lupu

. Estimate of current hospice and palliative medicine physician workforce shortage. J Pain Symptom Manage. 2010;40(6):899–911.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.16 MB

0.07 MB